Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Matt Boxer, Ph.D.
Chief Operating Officer
Veralox Therapeutics, Inc.
Poster(s):
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Wednesday, October 23, 2024
9:30 AM – 10:30 AM
MT